Slide 1: Exchange filing cover letter: Investor notes for Q4 and FY19 results
111141111 MOP EXTRAORDINARY PACKAGING 07 May 2019 Corporate Service Department The Listing Department BSE Limited National Stock Exchange of India Ltd 25th Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Mumbai 400 001 Bandra-Kurla Complex, Bandra (E) Mumbai 40
Slide 2: Essel Propack Limited Q4FY19 Earnings Update
Essel Propack Limited Q4FY19 Earnings Update 1 Investor's Note Q4FY19
Slide 3: Safe Harbour
Safe Harbour Certain statements in this presentation concerning our future growth prospects are forward-looking statements. The Company cautions that, by their nature, forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in such f
Slide 4: Essel Propack Proposition
Essel Propack Proposition Market leading position in attractive end markets Exceptional financial track with stable growth in oral record with industry care and increasing leading margins and cash penetration in non-oral generation. care markets. Best in class innovation Highly experienced platform
Slide 5: Consolidated Financial Highlights Q4FY19
Consolidated Financial Highlights Q4FY19 Total Income from Operations EBITDA and EBITDA Margins (INR Lacs) 18.7% 19.3% 10.4% 13.7% 11763 13371 62840 69367 Q4FY18 Q4FY19 Q4FY18 Q4FY19 EBIT and EBIT Margins PAT and EPS# (in INR) 12.1% 1.67 11.9% 1.43 12.6% 16.9% 8408 7465 4479 5238 Q4FY18 Q4FY19 Q4FY1
Slide 6: Consolidated Financial Highlights FY19
Consolidated Financial Highlights FY19 Total Income from Operations* EBITDA and EBITDA Margins (INR Lacs) 19.5% 18.5% 11.7% 6.0% 242388 270693 47286 50146 FY18 FY19 FY18 FY19 EBIT and EBIT Margins PAT and EPS# (in INR) 12.6% 6.12 11.6% 5.46 3.1% 12.2% 30579 31535 19253 17160 FY18 FY19 FY18 FY19 *YTD
Slide 7: Category-wise Revenue
Category-wise Revenue Oral Care Non-oral Care Oral Care Non-oral Care 40.4% 42.4% 42.7% 41.1% 59.6% 58.9% 57.6% 57.3% Q4FY18 Q4FY19 FY18 FY19 6 Investor's Note Q4FY19
Slide 8: Key Highlights
Key Highlights • On 22nd April 2019, private equity funds managed by Blackstone have entered into a definitive agreement with promoters of the Company to purchase 51% stake in the Company. The transaction is expected to complete in the coming months, subject to customary closing conditions and regul
Slide 9: Region-wise Revenue and EBIT Break-up
Region-wise Revenue and EBIT Break-up FY 19 Revenue Break-up % EBIT Break-up % 5% 21% 34% 25% AMESA 38% EAP Americas Europe 21% 24% 32% 8 Investor's Note Q4FY19
Slide 10: AMESA
AMESA (INR Lacs) Particulars Q4 FY19 Q4 FY18 % change FY 19 FY 18 % change Income from 23650 23292 1.5% 95962 91230 5.2% Operations EBIT 2935 3831 (23.4%) 12721 14124 (9.9%) EBIDTA Margin (%) 21.2% 24.0% 21.3% 23.2% • Egypt continued to post strong revenue growth for the quarter at 27.7% (18.0% on c
Slide 11: EAP
EAP (INR Lacs) Particulars Q4 FY19 Q4 FY18 % change FY 19 FY 18 % change Income from 15392 14257 8.0% 66730 57436 16.2% Operations EBIT 1587 1553 2.2% 10473 9061 15.6% EBIDTA Margin (%) 16.6% 17.3% 21.3% 21.7% • EAP revenue growth is helped by strong non-oral care category, resulting in an increase
Slide 12: Americas
Americas (INR Lacs) Particulars Q4 FY19 Q4 FY18 % change FY 19 FY 18 % change Income from 16486 12754 29.3% 58888 48846 20.6% Operations EBIT 3109 1502 107.0% 8180 6112 33.8% EBIDTA Margin (%) 23.7% 16.3% 18.7% 17.2% • In constant currency, revenue grew 18.9% for the quarter helped by both oral and
Slide 13: Europe
Europe (INR Lacs) Particulars Q4 FY19 Q4 FY18 % change FY 19 FY 18 % change Income from 16411 14,115 16.3% 58517 50959 14.8% Operations EBIT 1055 517 104.1% 1790 1200 49.2% EBIDTA Margin (%) 13.1% 10.9% 10.3% 10.0% • In constant currency, Europe revenue grew at 17.1% for the quarter contributed by g
Slide 14: Overall
Overall Overall the year ended with revenue growth from all regions except AMESA due to India Pharma Regulation Impact and lower offtake by key customers. Non oral care continues to be focus area with winning new contracts in Americas, Europe as well as EAP Regions. The Company had created capabilit
Slide 15: Proposed Final Dividend
Proposed Final Dividend FY19# Particulars FY17 FY18 (Proposed Dividend) Dividend per share 2.40 2.40 1.25 No of shares ( Lacs) 1571 1572 *3151 Total Dividend (INR Lacs) 3770 3772 3941 Dividend distribution tax (INR Lacs) 768 775 810 Total Dividend Outflow (INR Lacs) 4538 4547 4751 * 1:1 Bonus announ
Slide 16: Blackstone and Essel Propack Partnership
Blackstone and Essel Propack Partnership • Blackstone has committed up to $460M to acquire majority stake in Essel Propack • Blackstone will pay a purchase price of INR 134 per share to acquire a 51% shareholding from Ashok Goel Trust. • This transaction will trigger a mandatory open offer for a pur
Slide 17: An Introduction to Blackstone
An Introduction to Blackstone Blackstone – A Leading Investment Firm Private Equity Real Estate Hedge Fund Solutions Credit Businesses • AUM: $140 billion • AUM: $80 billion • AUM: $132 billion • AUM: $159 billion • Eight global funds and • Customized investment • Mezzanine / Rescue • Seven global f
Slide 18: Blackstone is committed to make Essel Propack a Global Leader
Blackstone is committed to make Essel Propack a Global Leader Across End-Categories Blackstone views Essel Propack as a growth investment with four key tenets: 1. Accelerate growth along two dimensions: o Fast growing end-categories: accelerate the ongoing industry shift towards laminated tubes to d
Slide 19: About Essel Propack
About Essel Propack Essel Propack is the largest specialty packaging global company, manufacturing laminated plastic tubes catering to the FMCG and Pharma space. Employing over 3158 people representing 25 different nationalities, Essel Propack functions through 20 state of the art facilities and in
Slide 20: Thank You
THANK YOU 3 Investor's Note Q4FY19